Infertility is a significant global health challenge impacting millions of families worldwide. Utilizing data from the Global ...

New genetic evidence suggests that people with an inherited tendency towards blood clots may be at higher risk of developing ...

Bloomberg’s t Global Regulatory Brief reviews recent global regulatory developments, focusing on the EU, US, UK, and Singapore, as they introduce regulations on trading, market structures, and ...

Night work keeps hospitals open, factories humming and deliveries moving while most people sleep, but a growing body of ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

Daiichi Sankyo &AstraZeneca’s Enhertu approved in China as first HER2 directed medicine for patients with HER2 low or HER2 ultralow metastatic breast cancer ...

Officials for the FDA have expanded its’ approval of pimobendan chewable tablets (Vetmedin; Boehringer Ingelheim) to include ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...

Basel: Roche has received approval from the US Food and Drug Administration (FDA) for CD20xCD3 bispecific Lunsumio VELO ...

The company reported progress on a key China trial and US regulatory resubmissions for two diagnostic imaging agents.

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety artefacts, evidence repeatability and lifecycle controls. CITY OF LONDON, GB / ACCESS ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...